louisiana glp-1 stomach paralysis class action RA Lawsuit - Shreveport Lawyer Ozempic Lawsuit [July 2026 Update]

Retatrutide vs Semaglutide: Evidence-based comparison of the investigational triple GIP/GLP-1/glucagon agonist versus the FDA-approved GLP-1 agonist

Not for human or animal consumption

More severe side effects include pancreatitis, cholelithiasis, ...

They follow what they hear

My take: GLP-1RAs may become more than metabolic drugs, but oncology needs prospective cancer-outcome data before calling this prevention

Notably, GLP-1RAs benefit pain management through their neuroprotective and metabolic regulatory properties, such as inhibiting inflammation responses and oxidative stress, promoting -endorphin release and modulating several other crucial biological pathways